Citations

Clear

1053 citation(s) found for "Andre, F".

Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells
Taipaleenmäki, Hanna , Farina, Nicholas H. , Wijnen, André J. van , Stein, Janet L. , Hesse, Eric , Stein, Gary S., Lian, Jane B. , van Wijnen, Andre J, van Wijnen, Andre J

Mayo Clinic

Oncotarget | October 12, 2016 | Volume: 7 | Issue: 48 | Pages: 79032-79046

10.18632/oncotarget.12593 | PMID 27738322 Get It

Cutaneous nodular fasciitis with genetic analysis: a case series
Kumar, Erica, Patel, Nimesh R. , Demicco, Elizabeth G. , Bovée, Judith V.M.G. , Olivera, Andre M., López‐Terrada, Dolores , Billings, Steven D. , Lazar, Alexander J. , Wang, Wei‐Lien , Lazar, Alexander J , Bovée, Judith V M G

Mayo Clinic

Journal of Cutaneous Pathology | September 30, 2016 | Volume: 43 | Issue: 12 | Pages: 1143-1149

10.1111/cup.12828 | PMID 27686647 Get It

Nodular fasciitis is a benign self‐limited myofibroblastic neoplasm, which usually involves the upper extremities and trunk of young patients. These tumors have been shown to harbor a translocation involving the MYH9 and USP6 genes, leading to overexpression of the latter. We report seven cases of nodular fasciitis with cutaneous presentations. All cases involved the dermis, with six involving the superficial subcutis, and one auricular tumor extending into cartilage. All cases showed USP6 rearrangement by fluorescence in situ hybridization; in two of three cases, the characteristic MYH9‐USP6 fusion was shown by RT‐PCR. All patients underwent conservative resection. Nodular fasciitis is an uncommon mesenchymal neoplasm that can occasionally present in superficial locations and is sometimes mistaken for a malignant process. Molecular testing can be useful to distinguish this entity from other cutaneous spindle cell tumors.
Safety of Intra-Articular Implantation of Oligo[Poly(ethylene glycol) Fumarate] Scaffolds into the Rabbit Knee
Ewald, Timothy J., Walker, Justin A. , Lewallen, Eric A. , Trousdale, William H. , Yaszemski, Michael J. , Hanssen, Arlen D. , Morrey, B.F. , Wijnen, André J. van , Morrey, Bernard F, van Wijnen, Andre J, Sanchez-Sotelo, Joaquin, Sánchez‐Sotelo, Joaquín , Morrey, Mark E. , Abdel, Matthew P. , van Wijnen, Andre J

Mayo Clinic

Tissue Engineering Part C: Methods | September 27, 2016 | Volume: 22 | Issue: 10 | Pages: 991-998

10.1089/ten.tec.2016.0209 | PMID 27673559 Get It

Identifying Nuclear Matrix‐Attached DNA Across the Genome
Dobson, Jason R. , Hong, Deli , Wu, Hai , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , Wijnen, André J. van , Nickerson, Jeffrey A. , van Wijnen, Andre J, Barutcu, A. Rasim , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | September 14, 2016 | Volume: 232 | Issue: 6 | Pages: 1295-1305

10.1002/jcp.25596 | PMID 27627025 Get It

Experimental approaches to define the relationship between gene expression and nuclear matrix attachment regions (MARs) have given contrasting and method‐specific results. We have developed a next generation sequencing strategy to identify MARs across the human genome (MAR‐Seq). The method is based on crosslinking chromatin to its nuclear matrix attachment sites to minimize changes during biochemical processing. We used this method to compare nuclear matrix organization in MCF‐10A mammary epithelial‐like cells and MDA‐MB‐231 breast cancer cells and evaluated the results in the context of global gene expression (array analysis) and positional enrichment of gene‐regulatory histone modifications (ChIP‐Seq). In the normal‐like cells, nuclear matrix‐attached DNA was enriched in expressed genes, while in the breast cancer cells, it was enriched in non‐expressed genes. In both cell lines, the chromatin modifications that mark transcriptional activation or repression were appropriately associated with gene expression. Using this new MAR‐Seq approach, we provide the first genome‐wide characterization of nuclear matrix attachment in mammalian cells and reveal that the nuclear matrix‐associated genome is highly cell‐context dependent. J. Cell. Physiol. 232: 1295–1305, 2017. © 2016 Wiley Periodicals, Inc.
Covalent crosslinking of graphene oxide and carbon nanotube into hydrogels enhances nerve cell responses
Liu, Xifeng , Park, Sungjo , Waletzki, Brian E., Yaszemski, Michael J. , Lu, Lichun , Miller, Alan Lee , Terzic, André

Mayo Clinic

Journal of Materials Chemistry B | September 6, 2016 | Volume: 4 | Issue: 43 | Pages: 6930-6941

10.1039/c6tb01722c | PMID 32263560 Get It

Chemically crosslinking GOa and CNTpega followed by in situ reduction fabricated a conductive rGOa–CNTpega–OPF hydrogel that strongly stimulated neurite growth.
In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors
Richter, Maximilian , Saydaminova, Kamola, Yumul, Roma , Krishnan, Rohini, Nagy, Eniko-Eva, Singh, Manvendra , Izsvák, Zsuzsanna , Cattaneo, Roberto , Uckert, Wolfgang, Palmer, Donna , Ng, Philip , Haworth, Kevin G. , Ehrhardt, Anja , Papayannopoulou, Thalia , Lieber, André , Liu, Jing , Kiem, Hans‐Peter

Mayo Clinic

Blood | August 23, 2016 | Volume: 128 | Issue: 18 | Pages: 2206-2217

10.1182/blood-2016-04-711580 | PMID 27554082 Get It

Abstract Current protocols for hematopoietic stem/progenitor cell (HSPC) gene therapy, involving the transplantation of ex vivo genetically modified HSPCs are complex and not without risk for the patient. We developed a new approach for in vivo HSPC transduction that does not require myeloablation and transplantation. It involves subcutaneous injections of granulocyte-colony-stimulating factor/AMD3100 to mobilize HSPCs from the bone marrow (BM) into the peripheral blood stream and the IV injection of an integrating, helper-dependent adenovirus (HD-Ad5/35++) vector system. These vectors target CD46, a receptor that is uniformly expressed on HSPCs. We demonstrated in human CD46 transgenic mice and immunodeficient mice with engrafted human CD34+ cells that HSPCs transduced in the periphery home back to the BM where they stably express the transgene. In hCD46 transgenic mice, we showed that our in vivo HSPC transduction approach allows for the stable transduction of primitive HSPCs. Twenty weeks after in vivo transduction, green fluorescent protein (GFP) marking in BM HSPCs (Lin−Sca1+Kit− cells) in most of the mice was in the range of 5% to 10%. The percentage of GFP-expressing primitive HSPCs capable of forming multilineage progenitor colonies (colony-forming units [CFUs]) increased from 4% of all CFUs at week 4 to 16% at week 12, indicating transduction and expansion of long-term surviving HSPCs. Our approach was well tolerated, did not result in significant transduction of nonhematopoietic tissues, and was not associated with genotoxicty. The ability to stably genetically modify HSPCs without the need of myeloablative conditioning is relevant for a broader clinical application of gene therapy.
Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer
André, Thierry , Sargent, Daniel J. , Grothey, Axel , André, Thierry

Mayo Clinic

Journal of Clinical Oncology | August 16, 2016 | Volume: 34 | Issue: 30 | Pages: 3711-3712

10.1200/jco.2016.68.4886 | PMID 27528725 Get It

Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below
Al‐Ibraheemi, Alyaa , Inwards, Carrie Y., Zreik, Riyam , Wenger, Doris E. , Jenkins, Sarah M. , Carter, Jodi M. , Boland, Jennifer M. , Rose, Peter S. , Jin, Long , Oliveira, André M. , Fritchie, Karen , Carter, Jodi

Mayo Clinic

American Journal of Surgical Pathology | August 12, 2016 | Volume: 40 | Issue: 12 | Pages: 1702-1712

10.1097/pas.0000000000000715 | PMID 27526293 Get It

Although the majority of giant cell tumors (GCTs) of the bone occur in adult patients, occasionally they arise in the pediatric population. In this setting they may be mistaken for tumors more commonly seen in this age group, including osteosarcoma, aneurysmal bone cyst, and chondroblastoma. All cases of primary GCT of the bone arising in patients 18 years and below were retrieved from our institutional archives and examined with emphasis on the evaluation of various morphologic patterns. Clinical/radiologic records were reviewed when available. Analysis for H3F3A/H3F3B mutations was performed in a subset of cases. Sixty-three (of 710) patients treated at our institution for GCT were 18 years of age and below. The following morphologic patterns were identified: fibrosis (31 cases, 49%), reactive-appearing bone (26, 41%), cystic change (7, 11%), foamy histiocytes (6, 10%), secondary aneurysmal bone cyst (3, 5%), and cartilage (2, 3%). Infarct-like necrosis was present in 17 tumors (27%), and the mitotic rate ranged from 0 to 35 mitoses/10 high-power fields (median 5 mitoses/10 high-power field). Follow-up information (n=55; 6 mo to 69.6 y; median, 11.6 y) showed 21 patients with local recurrence (38%) and 2 patients with lung metastasis (4%). Polymerase chain reaction with sequencing showed that 5 of 5 tested cases harbored H3F3A mutations. In summary, GCT arising in the pediatric population is rare, representing 9% of GCTs seen at our institution. The morphologic spectrum of these tumors is broad and similar to that seen in patients above 18 years of age. It is important to recognize that matrix formation may be observed in GCT, including reactive-appearing bone and cartilage, as well as areas of fibrosis mimicking osteoid production, to avoid misclassification as osteosarcoma or other giant cell–rich lesions common in children.
Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling
Carpio, Lomeli R., Bradley, Elizabeth W. , Weivoda, Megan , Poston, Daniel , Dudakovic, Amel , Xu, Ming , Tchkonia, Tamar , Kirkland, James L. , Wijnen, André J. van , Oursler, Merry Jo, Shull, Lomeli C. , Weivoda, Megan M, Poston, Daniel D, van Wijnen, Andre J, McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J. , van Wijnen, Andre J , Bradley, Elizabeth W , Xu, Ming , Tchkonia, T

Mayo Clinic

Science Signaling | August 9, 2016 | Volume: 9 | Issue: 440 | Pages: No page available

10.1126/scisignal.aaf3273 | PMID 27507649 Get It

Histone deacetylase 3 prevents chondrocytes from producing inflammatory mediators that prevent bone development.